Skip to main content
Premium Trial:

Request an Annual Quote

Travis Lacey, Dale Gordon, Gary Altman, Steven Ness

Human Longevity has hired several new senior staff. Travis Lacey was named chief corporate development officer; Dale Gordon was named chief commercial officer; Gary Altman was named chief operating officer; and Steven Ness was named chief services lead. Lacey comes from GE Healthcare where he was the managing director, leading the divestiture practice and portfolio optimization. Before that he was with investment banks Jefferies and R.W. Baird. Gordon was most recently GM of account management at GE Healthcare. Prior to that, he was with EMD Millipore, now Millipore Sigma and part of Merck KGaA. Altman has more than 25 years of experience leading startups and has served as CEO, COO, VP, and GM at various firms. Ness most recently was director of client services at GE Healthcare's Clarient Diagnostics business. Previously, he held medical affairs and marketing positions at Quidel. 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.